title: Which non-small-cell lung cancer patients achieve long-term survival?
authors.forename: N
authors.initials: N
authors.lastname: Ahbeddou
authors.forename: M
authors.initials: M
authors.lastname: Fetohi
authors.forename: S
authors.initials: S
authors.lastname: Boutayeb
authors.forename: H
authors.initials: H
authors.lastname: Errihani
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology*; D059248:Chemoradiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D018572:Disease-Free Survival; D006801:Humans; D007633:Keratins / Q000378:metabolism; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012074:Remission Induction; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D007633:Keratins; D002945:Cisplatin; D000077235:Vinorelbine